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SPECT IMAGING OF MOYAMOYA DISEASE USING 
ggmTc-HM-PAO 
COMPARISON WITH COMPUTED TOMOGRAPHY FINDINGS 
JAMES M. MOUNTZ, MD, PhD, NORMAN L. FOSTER, MD, 
ROBERT J. ACKERMANN, CNMT, LAURIE BLUEMLEIN, BSN, 
MS, NEIL A. PETRY, MS, RPh AND DAVID E. KUHL, MD 
gg”Tc-HM-PAO was used to evaluate regional cere- 
bral blood flow in a 26-year-old woman with Moy- 
amoya disease. This patient had an 18-month his- 
tory of recurrent neurologic deficits and had 
angiographic evidence of Moyamoya disease. She 
had used oral contraceptives and cigarettes, but had 
no other risk factors for stroke. Single photon emis- 
sion computed tomographic images showed bilat- 
eral and asymmetric reductions in blood flow to an- 
terior and lateral brain regions. These findings 
correlated better with clinical symptomatology and 
suggested more extensive brain involvement than 
did computed tomography. 
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Cerebral blood flow imaging with single photon 
emission computed tomography (SPECT) has 
proven useful in the evaluation of stroke and tran- 
sient ischemia attacks (l-4). Although several ra- 
dionuclide blood flow agents are used for SPECT 
imaging of the brain, we chose the compound 
““Tc-HM-PA0 because it depicts excellent blood 
flow images (5), has more counts per administered 
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dose compared with the ““I-labeled compounds, 
and can be easily prepared from a kit that is in- 
jected with sodium pertechnetate obtained from a 
standard ggMolggmT~ generator. 
Moyamoya disease is a rare cause of stroke that 
can present clinically in young adults as chronic 
progressive ischemia or recurrent stroke (6,7). Ce- 
rebral angiography characteristically shows narrow- 
ing or occlusion of the distal internal carotid arter- 
ies associated with a profuse vascular network in 
the basal ganglia. Cerebral hemodynamics in pa- 
tients with Moyamoya disease usually show a pat- 
tern of bilateral low mean hemispheric blood flow 
with low regional blood flow to the frontal hemi- 
spheres (8). 
CASE REPORT 
A 26-year-old right-handed woman was well until 
18 months prior to admission when she developed 
recurrent, transient episodes of right arm numbness 
and weakness and difficulty with her speech. Three 
months prior to admission the patient awoke with 
left leg weakness and incoordination that slowly im- 
proved. At the time of admission the patient had a 
new episode of left arm and leg weakness and numb- 
ness and difficulty with speech. The neurologic ex- 
amination demonstrated a nonfluent aphasia, and 
there was weakness and numbness involving the 
entire left arm and leg as well as residual neurologic 
impairment involving the right side of the body. 
She had been taking oral contraceptives and smok- 
ing two packs of cigarettes per day. A cranial com- 
puted tomography (CT) scan was performed (Figure 
1) at the time of the SPECT scan and showed a 
small left centrum semiovale lacunar infarct and an 
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FIGURE 1. CT transverse section of the brain showing a 
region of low attenuation in the high left parietal lobe (ar- 
row) representing the left parietal infarction. The small 
left centrum semiovale lacunar infarct is seen just medial 
to the cortical infarct. 
area of cortical substance loss in the high left mid- 
parietal region consistent with an old infarction. A 
cerebral angiogram was performed (Figure 2) that 
showed bilateral narrowing of the supraclinoid ar- 
teries, measured to be 30% of normal diameter on 
the right and 20% of normal diameter on the left. 
There was a prominent collateral network of vessels 
extending into the basal ganglia (the Moyamoya 
vessels). 
METHODS 
gg”Tc-Hexamethylpropyleneamine oxime (ggmTc- 
HM-PAO) (Ceretec, Amersham Corporation, Arling- 
ton Heights, IL) is a new lipophilic brain bloodflow 
imaging agent with high brain uptake and retention 
without evidence of redistribution for at least 8 
hours (5, 9-11). The utilization of ““Tc-HM-PA0 
in patients with stroke was approved by the Human 
Studies Committee of the University of Michigan. 
Unit dose kits for the preparation of ggmTc-HM- 
PA0 were supplied by the Amersham Corporation 
and were reconstituted with 25-30 mCi of sodium 
pertechnetate in 5 mL of sterile saline eluated from 
FIGURE 2. Lateral skull angiogram showing narrowing of 
the supraclinoid portions of the internal carotid artery 
(arrow) and the Moyamoya vessels [arrowhead). 
a commercially available ggMo/gg”T~ generator. 
Chromatographic analysis at the time of administra- 
tion indicated that 98% of the administered activity 
was associated with the desired lipophilic ggmT~- 
HM-PA0 complex. After receiving IV bolus of 19.8 
mCi of ““Tc-HM-PAO, imaging was performed us- 
ing a General Electric 400AC gamma camera 
equipped with an all-purpose collimator interfaced 
to a Siemens Micro-Delta computer. Five million to- 
tal counts were obtained over 64 angular views, 25 
seclstop, 64 stops. 
Regions of Interest and Qualitative Estimation 
of Cerebral Blood Flow 
Computed tomographic volume sizes were deter- 
mined by hand drawing regions around brain tissue 
loss (presumed infarcted), summing the areas, and 
multiplying by the CT plane width. For quantifica- 
tion of cerebral blood flow, arterial sampling needs 
to be performed to provide the tracer input function 
to the brain for the application of a kinetic model 
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(12). Because arterial sampling was not done, a 
qualitative analysis was performed by comparing 
ratios of tracer uptake in regions of suspected ab- 
normality with the tracer uptake within the whole 
slice containing the abnormality. These ratios were 
compared with ratios obtained from mirrored re- 
gions of interest taken from the contralateral hemi- 
sphere. Volume sizes on the SPECT images were 
determined by hand drawing regions around areas 
of visibly decreased tracer activity (presumed to be 
regions of diminished blood flow) on each image 
and summing the total pixels (1 pixel = 0.625 cm3). 
RESULTS 
The ggmTc-HM-PAO SPECT scan showed a flow de- 
fect involving a large portion of the left parietal cor- 
tex, with a second focal area of decreased flow in 
the “watershed” area of the left anterior cerebral/ 
middle cerebral arteries (Figure 3). The scan also 
showed slightly diminished tracer uptake involving 
the right parietal and frontal cortex. The size of the 
area of decreased flow in the mid-left parietal region 
seen on the SPECT images was much larger than 
suggested by the CT scan. The size of the region of 
decreased flow was measured to involve 78 cm3 of 
FIGURE 3. g9mTc-HM-PA0 SPECT scan, transverse sec- 
tion showing region of decreased flow in the midleft pa- 
rietal cortex (arrow) and anterior left frontal-parietal re- 
gion [arrowhead). The right parietal and frontal cortex 
also demonstrates slightly decreased tracer uptake. 
brain, while the size of cortical volume loss pre- 
sumed due to infarction measured by CT was 3.4 
cm3. The parietal cortex flow ratio, measured 
through the region of abnormality from the coronal 
projection, was left to right, .66, representing a sig- 
nificant diminution of flow to the left parietal cortex 
compared with the flow in the corresponding region 
of the right parietal cortex. 
DISCUSSION 
gg”Tc-HM-PAO is a new brain bloodflow tracer that 
has the ideal radiopharmacologic properties of ease 
of preparation, relatively high brain uptake, and sta- 
bility in the brain (10). It also has the ideal imaging 
properties associated with its 140 keV gamma emis- 
sion, which is routinely imaged by the standard An- 
ger gamma camera. These advantages allow the 
tracer to provide excellent images of cerebral blood 
flow without the limitations of some of the earlier 
agents (5). 
Moyamoya disease is a relatively rare disease 
that usually presents as progressive ischemia or 
stroke in children. The case presented here is unu- 
sual because our patient was older. In addition, the 
patient was taking oral contraceptives and smoked 
two packs of cigarettes per day. These two factors 
appear to increase the risk of developing Moyamoya 
in young women, and it has been suggested that im- 
provement occurs when those factors are discontin- 
ued (13). Follow-up serial examinations of cerebral 
blood flow in these patients using ggmTc-HM-PAO 
SPECT might provide objective evidence of this 
pathogenetic mechanism. Noninvasive determina- 
tion of regional blood flow by SPECT was superior 
to CT in demonstrating the extent and location of 
this patient’s neurologic impairment. The SPECT 
images showed bilaterally decreased anterior brain 
circulation (explaining both the right- and left-sided 
symptoms), and, unlike the CT scan, demonstrated 
a lesion in the left anterior/middle cerebral artery 
distribution, explaining the patient’s nonfluent 
aphasia. The larger area of flow deficit in the left 
parietal region was a better reflection of the signifi- 
cant loss of both upper and lower extremity sensory 
and motor function on the right side of the body, 
whereas CT suggested a lesser deficit. Moyamoya 
causes progressive ischemic changes due to gradual 
narrowing of proximal portions of the major intra- 
cranial vessels. The slow development of this nar- 
rowing permits collateral circulation to develop, in 
part, to compensate for these changes. If collaterals 
prove to be completely insufficient, infarction de- 
velops and deficits become fixed with correspond- 
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ing loss of brain substance, as represented in the left 
parietal region in our patient. On the other hand, 
when collateral development is insufficient to per- 
mit adequate perfusion, but adequate to prevent in- 
farction, deficits are reversible and do not cause loss 
of structural integrity. Consequently, Moyamoya 
disease serves as an ideal clinical model for revers- 
ible ischemic neurologic deficits. Such ischemic re- 
gions are well documented in the present study, 
both in the “penumbra” surrounding the left pari- 
eta1 infarct seen by CT and in the right hemisphere 
where clinical symptoms developed with interme- 
diate decreases in blood flow but without tissue de- 
struction. Thus, in this patient the ““Tc-HM-PA0 
SPECT study both presages the extent of brain sub- 
ject to future infarction and offers a noninvasive 
method of evaluating benefits from further thera- 
peutic interventions. 
CONCLUSION 
““Tc-HM-PA0 SPECT scanning of the brain can be 
easily performed and yields clinically relevant in- 
formation about regional cerebral blood flow. The 
areas of abnormality seen on SPECT scanning ap- 
pear more extensive than revealed by CT scanning 
alone, and more closely reflect the nature and prob- 
able source of the patient’s symptoms. By providing 
a noninvasive method of measuring blood flow, the 
cause of Moyamoya disease and its response to 
therapy can be further evaluated. 
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